Australian sub-analysis of the EPIC-Skin Study presented at ACD ASM 2026
At the 58th Annual Scientific Meeting of the Australasian College of Dermatologists (ACD ASM) in Melbourne, Australia, OncoBeta presented an Australian sub-analysis from the Phase IV EPIC-Skin Study. The presentation, delivered by A/Prof Chris Baker, provided insights into Australian patient outcomes and clinical experience with Rhenium-SCT® in the treatment of non-melanoma skin cancer. The data contributed to the ongoing scientific discussion around evidence generation and real-world clinical application in dermatology.
View scientific presentation: ACD 2026 Poster